OSTX · OS Therapies Inc · Documents
$1.26
-0.01 (-0.79%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$58.58M
Shares
46.13M
Volume · Oct 20
320.66K
Avg daily vol (3M)
581.44K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2025-03-31 | — | |
| 10-K | — | 2025-03-31 | 2024-12-31 | |
| DEF 14A | — | 2025-02-28 | 2025-03-31 | |
| PRE 14A | — | 2025-02-07 | — | |
| S-1 | — | 2025-01-31 | — | |
| 8-K | — | 2025-01-29 | 2025-01-28 | |
| 8-K | — | 2025-01-15 | 2025-01-14 | |
| 8-K | — | 2025-01-14 | 2025-01-10 | |
| 8-K | — | 2025-01-03 | 2024-12-31 | |
| S-1/A | — | 2025-01-03 | — | |
| 8-K | — | 2024-12-30 | 2024-12-24 | |
| S-1/A | — | 2024-11-27 | — | |
| 8-K | — | 2024-11-15 | — | |
| 10-Q | — | 2024-11-15 | 2024-09-30 | |
| NT 10-Q | — | 2024-11-14 | 2024-09-30 | |
| S-1 | — | 2024-11-12 | — | |
| 8-K | — | 2024-11-01 | 2024-10-31 | |
| 8-K | — | 2024-10-28 | — | |
| 8-K | — | 2024-08-22 | — | |
| 8-K | — | 2024-08-15 | — | |
| 10-Q | — | 2024-08-14 | 2024-06-30 | |
| S-1/A | — | 2024-06-13 | — | |
| S-1/A | — | 2024-06-07 | — | |
| S-1 | — | 2024-05-30 | — | |
| 10-Q | — | 2024-05-20 | 2024-03-31 | |
| NT 10-Q | — | 2024-05-15 | 2024-03-31 | |
| NT 10-K | — | 2024-05-15 | 2023-12-31 | |
| S-1/A | — | 2024-01-25 | — | |
| S-1/A | — | 2023-12-22 | — | |
| S-1/A | — | 2023-05-22 | — | |
| S-1/A | — | 2023-04-24 | — | |
| S-1/A | — | 2023-04-13 | — | |
| S-1 | — | 2023-03-31 | — |
Showing 51–83 of 83 filings